Form 4: Bio Green Med Director Sells Over 95,000 Shares

Kua Khai Loon, a Director and 10% owner of Bio Green Med Solution, Inc., reported selling a significant number of common shares in two separate, pre-planned transactions.

Summary

• Kua Khai Loon, identified as a Director and 10% owner of Bio Green Med Solution, Inc. (BGMS), reported transactions involving the sale of common stock.
• The transactions were made pursuant to a Rule 10b5-1(c) contract, instruction, or written plan for the purchase or sale of equity securities.
• On October 15, 2025, Kua Khai Loon disposed of 7,479 shares of common stock at a price of $5.661 per share.
• Following this transaction, beneficial ownership stood at 330,681 shares.
• On October 16, 2025, an additional 88,204 shares of common stock were disposed of at a price of $4.217 per share.
• After the second transaction, Kua Khai Loon's beneficial ownership decreased to 242,477 shares.
• The total number of shares sold across both transactions was 95,683.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to significant insider selling by a director and 10% owner. While the 10b5-1 plan mitigates some concerns, the reduction in ownership and the declining sale price between transactions are generally viewed unfavorably by the market.

Positives

• The sales were conducted under a Rule 10b5-1(c) plan, indicating they were pre-scheduled and not based on new, undisclosed material information, which can mitigate concerns about insider selling.

Negatives

• A Director and 10% owner significantly reduced their stake in the company, which can be perceived as a negative signal regarding future prospects or valuation.
• The price per share for the second, larger transaction ($4.217) was notably lower than the first transaction ($5.661), indicating a decline in the stock price between the two sale dates.

Risks

• Insider selling, even if pre-planned, can sometimes lead to negative market sentiment and put downward pressure on the stock price.
• A reduction in ownership by a significant insider might be interpreted by investors as a lack of confidence in the company's long-term growth or current valuation.

Future Outlook

The filing does not contain any forward-looking statements or guidance regarding the company's future performance or strategic direction.

Industry Context

This filing reports an individual insider transaction and does not provide broader industry context or trends. Insider transactions are common across all industries, and their significance is often evaluated in the context of the specific company's performance and market conditions.

Related Party Transactions

• The reported transactions involve the sale of common stock by Kua Khai Loon, a Director and 10% owner of Bio Green Med Solution, Inc., which constitutes a related party transaction.

Stakeholder Impact

• Shareholders may perceive the insider selling as a negative signal, potentially leading to decreased confidence and downward pressure on the stock price.
• The reduction in ownership by a significant insider could influence investor sentiment and trading decisions.

Key Dates

Recommendation

While the insider selling by a Director and 10% owner is a negative data point, especially with the declining sale price, the fact that it was executed under a Rule 10b5-1 plan suggests it was pre-planned and not necessarily a reaction to new, adverse company-specific news. Without additional information on the company's financial performance or strategic outlook, a 'hold' recommendation is appropriate, advising investors to monitor future developments and broader market trends for BGMS.

Keywords

Bio Green Med Solution, BGMS, Insider Selling, Form 4, Kua Khai Loon, Stock Sale, 10b5-1 Plan, Director Transaction, 10% Owner